CLDX EBITDA | Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (CLDX) EBITDA

2026-06-30: Basis Reported; EBITDA -$79.72M*; Operating income -$80.62M; Depreciation and amortization $902.00K*.
2026-03-31: Basis Reported; EBITDA -$83.58M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$86.34M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$72.79M*; Operating income -$73.62M; Depreciation and amortization $824.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$79.72M*	-$80.62M	$902.00K*	$22.00K	-362368.18%*	$3.18M*	-$57.41M*	(m)	$67.54M	(m)	(m)
2026-03-31	Reported	-$83.58M	(m)	(m)	(m)	-557206.67%	$1.64M	-$65.59M	(m)	$73.00M	(m)	(m)
2025-12-31	Reported	-$86.34M	(m)	(m)	(m)	-71352.89%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$72.79M*	-$73.62M	$824.00K*	$0.00*	(m)	$440.00K*	-$48.63M*	(m)	$62.93M	(m)	(m)
2025-06-30	Reported	-$62.98M*	-$63.86M	$873.00K*	$730.00K	-8627.95%*	$728.00K*	-$44.01M*	(m)	$54.20M	(m)	(m)
2025-03-31	Reported	-$61.87M	(m)	(m)	(m)	-8902.45%	$265.00K	-$54.37M	(m)	$52.61M	(m)	(m)
2024-12-31	Reported	-$55.21M	(m)	(m)	(m)	-4698.55%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$51.34M*	-$52.13M	$786.00K*	$3.19M	-1608.90%*	$545.00K*	-$55.34M*	(m)	$45.26M	(m)	(m)
2024-06-30	Reported	-$45.52M*	-$46.32M	$797.00K*	$2.50M	-1822.26%*	$274.00K*	-$29.33M*	(m)	$39.69M	(m)	(m)
2024-03-31	Reported	-$39.83M	(m)	(m)	(m)	-25533.97%	$344.00K	-$40.64M	(m)	$31.66M	(m)	(m)
2023-12-31	Reported	-$46.87M	(m)	(m)	(m)	-1134.54%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$40.47M*	-$41.24M	$767.00K*	$1.52M	-2667.90%*	$157.00K*	-$18.99M*	(m)	$34.53M	(m)	(m)
2023-06-30	Reported	-$32.45M*	-$33.20M	$756.00K*	$268.00K	-12107.84%*	$410.00K*	-$27.20M*	(m)	$26.25M	(m)	(m)
2023-03-31	Reported	-$31.75M	(m)	(m)	(m)	-3282.83%	$585.00K	-$28.57M	(m)	$26.80M	(m)	(m)
2022-12-31	Reported	-$27.21M	(m)	(m)	(m)	-1687.04%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$27.02M*	-$27.70M	$671.00K*	$407.00K	-6640.05%*	$345.00K*	-$35.19M*	(m)	$21.57M	(m)	(m)
2022-06-30	Reported	-$35.66M*	-$36.40M	$741.00K*	$163.00K	-21874.23%*	$673.00K*	-$22.24M*	(m)	$20.73M	(m)	(m)
2022-03-31	Reported	-$22.45M	(m)	(m)	(m)	-12900.00%	$575.00K	-$24.53M	(m)	$17.06M	(m)	(m)
2021-12-31	Reported	-$19.56M	(m)	(m)	(m)	-5857.19%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$20.07M*	-$20.82M	$752.00K*	$153.00K	-13118.95%*	$185.00K*	-$16.37M*	(m)	$13.56M	(m)	-$227.00K
2021-06-30	Reported	-$12.68M*	-$13.44M	$764.00K*	$3.48M	-364.25%*	$143.00K*	-$11.93M*	(m)	$12.36M	(m)	(m)
2021-03-31	Reported	-$15.86M	(m)	(m)	(m)	-2315.91%	$567.00K	-$18.08M	(m)	$12.72M	(m)	(m)
2020-12-31	Reported	-$24.03M	(m)	(m)	(m)	-634.77%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$13.48M*	-$14.34M	$861.00K*	$668.00K	-2018.11%*	$160.00K*	-$11.86M*	(m)	$10.71M	(m)	$0.00*
2020-06-30	Reported	-$10.22M*	-$11.37M	$1.15M*	$236.00K	-4329.24%*	$910.00K*	-$11.22M*	(m)	$9.71M	(m)	-$200.00K
2020-03-31	Reported	-$11.7M	(m)	(m)	(m)	-428.96%	$235.00K	-$12.11M	(m)	$11.70M	(m)	(m)
2019-12-31	Reported	-$11.84M	(m)	(m)	(m)	-1335.29%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$10.64M*	-$11.84M	$1.21M*	$546.00K	-1947.99%*	$142.00K*	-$11.14M*	(m)	$11.10M	(m)	(m)
2019-06-30	Reported	-$11.10M*	-$12.26M	$1.15M*	$715.00K	-1553.01%*	$298.00K*	-$11.04M*	(m)	$10.08M	(m)	(m)
2019-03-31	Reported	-$16.59M	(m)	(m)	(m)	-1164.14%	$186.00K	-$13.23M	(m)	$11.15M	(m)	(m)
2018-12-31	Reported	-$11.4M	(m)	(m)	(m)	-646.37%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$6.93M*	-$7.76M	$835.00K*	$941.00K	-736.34%*	$60.00K*	-$14.39M*	(m)	$11.92M	(m)	$0.00*
2018-06-30	Reported	-$15.88M*	-$16.87M	$993.00K*	$2.76M	-574.74%*	$332.00K*	-$17.39M*	(m)	$21.45M	(m)	$0.00*
2018-03-31	Reported	-$118.65M	(m)	(m)	(m)	-2916.64%	$259.00K	-$28.02M	(m)	$21.88M	(m)	-$765.00K
2017-12-31	Reported	-$24.5M	(m)	(m)	(m)	-709.03%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$30.94M*	-$31.96M	$1.02M*	$3.92M	-788.38%*	$282.00K*	-$24.36M*	(m)	$21.91M	(m)	-$5.20M
2017-06-30	Reported	-$27.93M*	-$28.93M	$1.00M*	$3.83M	-729.35%*	$942.00K*	-$20.79M*	(m)	$25.00M	(m)	(m)
2017-03-31	Reported	-$33.75M	(m)	(m)	(m)	-2199.87%	$374.00K	-$35.26M	(m)	$25.79M	(m)	(m)
2016-12-31	Reported	-$33.89M	(m)	(m)	(m)	-1809.50%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$29.29M*	-$29.99M	$701.00K*	(m)	(m)	$806.00K*	-$23.95M*	(m)	$25.01M	(m)	(m)
2016-06-30	Reported	-$31.67M*	-$32.37M	$692.00K*	(m)	(m)	$767.00K*	(m)	(m)	$25.71M	(m)	(m)
2016-03-31	Reported	-$34.96M	(m)	(m)	(m)	-2683.19%	$540.00K	(m)	(m)	$27.45M	(m)	(m)
2015-12-31	Reported	-$32.59M	(m)	(m)	(m)	-1819.71%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$31.60M*	-$32.37M	$767.00K*	(m)	(m)	$1.36M*	(m)	(m)	$24.66M	(m)	(m)
2015-06-30	Reported	-$32.04M*	-$32.75M	$712.00K*	(m)	(m)	$1.55M*	(m)	(m)	$26.49M	(m)	(m)
2015-03-31	Reported	-$30.31M	(m)	(m)	(m)	-6236.42%	$1.56M	(m)	(m)	$25.13M	(m)	(m)
2014-12-31	Reported	-$31.43M	(m)	(m)	(m)	-2127.76%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$29.74M*	-$30.34M	$603.00K*	(m)	(m)	$672.00K*	(m)	(m)	$26.18M	(m)	(m)
2014-06-30	Reported	-$27.97M*	-$28.55M	$582.00K*	(m)	(m)	$899.00K*	(m)	(m)	$24.10M	(m)	(m)
2014-03-31	Reported	-$30.91M	(m)	(m)	(m)	-7430.29%	$195.00K	(m)	(m)	$27.07M	(m)	(m)
2013-12-31	Reported	-$21.6M	(m)	(m)	(m)	-3484.52%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$22.79M*	-$23.27M	$479.00K*	(m)	(m)	$984.00K*	(m)	(m)	$20.42M	(m)	(m)
2013-06-30	Reported	-$18.18M*	-$18.66M	$475.00K*	(m)	(m)	$755.00K*	(m)	(m)	$15.09M	(m)	(m)
2013-03-31	Reported	-$16.93M	(m)	(m)	(m)	-701.45%	$162.00K	(m)	(m)	$14.09M	(m)	(m)
2012-12-31	Reported	-$16.08M	(m)	(m)	(m)	-440.88%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$14.25M*	-$14.75M	$503.00K*	(m)	(m)	$71.00K*	(m)	(m)	$11.77M	(m)	(m)
2012-06-30	Reported	-$12.96M*	-$13.49M	$529.00K*	(m)	(m)	$80.00K*	(m)	(m)	$11.11M	(m)	(m)
2012-03-31	Reported	-$12.74M	(m)	(m)	(m)	-523.80%	$42.00K	(m)	(m)	$10.77M	(m)	(m)
2011-12-31	Reported	-$11.83M	(m)	(m)	(m)	-486.07%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$10.91M*	-$11.48M	$566.00K*	(m)	(m)	$121.00K*	(m)	(m)	$8.59M	(m)	(m)
2011-06-30	Reported	-$9.31M*	-$9.88M	$568.00K*	(m)	(m)	$80.00K*	(m)	(m)	$7.17M	(m)	(m)
2011-03-31	Reported	-$9.1M	(m)	(m)	(m)	-361.53%	$202.00K	(m)	(m)	$6.85M	(m)	(m)
2010-12-31	Reported	$21.65M	(m)	(m)	(m)	57.38%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$8.30M*	-$8.88M	$580.00K*	(m)	(m)	$533.00K*	(m)	(m)	$7.21M	(m)	(m)
2010-06-30	Reported	(m)	-$9.29M	(m)	(m)	(m)	(m)	(m)	(m)	$7.26M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$283.99M	(m)	(m)	(m)	-18381.04%	$2.71M	-$210.94M	$200.00K	$245.07M	(m)	$0.00
2024-12-31	Reported	-$191.9M	(m)	(m)	(m)	-2733.63%	$1.92M	-$157.78M	$200.00K	$163.55M	(m)	$0.00
2023-12-31	Reported	-$151.53M	(m)	(m)	(m)	-2201.57%	$1.82M	-$107.29M	$300.00K	$118.01M	(m)	$0.00
2022-12-31	Reported	-$112.34M	(m)	(m)	(m)	-4766.14%	$1.83M	-$103.73M	$100.00K	$82.26M	(m)	(m)
2021-12-31	Reported	-$68.18M	(m)	(m)	(m)	-1465.81%	$1.25M	-$60.91M	$100.00K	$53.31M	(m)	-$227.00K
2020-12-31	Reported	-$59.43M	(m)	(m)	(m)	-801.09%	$1.55M	-$40.40M	$200.00K	$42.53M	(m)	-$1.17M
2019-12-31	Reported	-$50.17M	(m)	(m)	(m)	-1404.23%	$731.00K	-$46.41M	$100.00K	$42.67M	(m)	(m)
2018-12-31	Reported	-$152.86M	(m)	(m)	(m)	-1602.63%	$813.00K	-$75.23M	$700.00K	$66.45M	(m)	-$765.00K
2017-12-31	Reported	-$117.11M	(m)	(m)	(m)	-919.04%	$1.79M	-$99.93M	$700.00K	$96.17M	(m)	-$24.28M
2016-12-31	Reported	-$129.82M	(m)	(m)	(m)	-1913.07%	$2.75M	-$113.04M	$1.60M	$102.73M	(m)	(m)
2015-12-31	Reported	-$126.54M	(m)	(m)	(m)	-2309.18%	$4.88M	-$98.89M	(m)	$100.17M	(m)	(m)
2014-12-31	Reported	-$120.04M	(m)	(m)	(m)	-3347.52%	$1.93M	(m)	(m)	$104.38M	(m)	(m)
2013-12-31	Reported	-$79.51M	(m)	(m)	(m)	-1934.08%	$4.22M	(m)	(m)	$67.40M	(m)	$0.00
2012-12-31	Reported	-$56.03M	(m)	(m)	(m)	-500.18%	$303.00K	(m)	(m)	$47.40M	(m)	$0.00
2011-12-31	Reported	-$41.15M	(m)	(m)	(m)	-444.16%	$509.00K	(m)	(m)	$32.44M	(m)	(m)
2010-12-31	Reported	-$3.74M	(m)	(m)	(m)	-7.99%	$2.10M	(m)	(m)	$27.65M	(m)	(m)
2009-12-31	Reported	-$34.27M	(m)	(m)	(m)	-225.74%	$528.00K	(m)	(m)	$26.17M	(m)	-$529.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEOGEN CORP (NEOG)	United States	$2.979B	-247.49
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
BIOMERICA INC (BMRA)	United States	$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)	United States	$0.008B	-1.93